Cargando…
Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
Heat shock protein 90 (Hsp90) is a conserved and constitutively expressed molecular chaperone and it has been shown to stabilize oncoproteins and facilitate cancer development. Hsp90 has been considered as a therapeutic target for cancers and three classes of Hsp90 inhibitors have been developed: (1...
Autores principales: | Ho, Ngoc, Li, Adam, Li, Shaoguang, Zhang, Haojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763672/ https://www.ncbi.nlm.nih.gov/pubmed/24280675 http://dx.doi.org/10.3390/ph5080779 |
Ejemplares similares
-
Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
por: Giubellino, Alessio, et al.
Publicado: (2013) -
Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
por: Wu, Xinqi, et al.
Publicado: (2013) -
The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin
por: Kumar, Rajinder, et al.
Publicado: (2003) -
Potential role of heat shock protein 90 (Hsp90) in HIV uncoating
por: Joshi, Pheroze, et al.
Publicado: (2011) -
Heat shock protein 90 inhibitors repurposed against Entamoeba histolytica
por: Shahinas, Dea, et al.
Publicado: (2015)